Orionis Biosciences

Technologiepark 94
9052 Zwijnaarde
BE
Orionis Biosciences
Foundation date
01/09/2015
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
We are an early stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical need – with an initial internal focus in oncology and immunotherapies.
Upcoming events
All events-
0310 '23
-
1810 '23
EMDS2023@VIB
Event by: VIB -
1212 '23
BioFIT 2023
Event by: Eurasanté
Latest news
More news-
argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis
Thursday September 21st 2023
Read more
-
Galapagos appoints Simon Sturge to its Board of Directors
Tuesday September 19th 2023
Read more
-
13th Investment for HERAN Partners: Broken String Biosciences (UK)
Tuesday September 19th 2023
Read more
Jobs by Orionis Biosciences
More jobs-
21/09/23
East Flanders
Technician Protein Production and Characterization
Permanent
Orionis Biosciences